Genmab — April 2020

[E_L]

Phase Ib/II trial of tisotumab vedotin (TV) ± bevacizumab (BEV), pembrolizumab (PEM), or...

[E_L]

Epcoritamab (GEN3013; DuoBody-CD3×CD20) to induce complete response in patients with...

[E_L]

Phase I study of teclistamab, a humanized B-cell maturation antigen (BCMA) x CD3 bispecific...

[E_L]

Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20...

[E_L]

and 7 results
for Dara

[GeorgeBest]

Thanks E L, så usual you were the fastest

[GeorgeBest]

as usual

[JørgenVarnæs]

Nice. Could be grelt
Winther another run at the throne in cll

[JørgenVarnæs]

iPad

[Solsen]

Nu skal jeg til at have noter til alle de vanskelige navne

[Bulder]

Gider du ikke poste dem, når du har skrevet dem allesammen ned

[Bulder]

Jeg kan ikke få den søgemaskine til at virke. Var der noget om Andromeda?

[Bulder]

E L I still cannot make asco's search machine work. You didn't see InnovaTV204? Only 205? And no Andromeda?

[E_L]

No and no

[E_L]

ASCO tweet says : Thanks for your patience as #ASCO20 abstract titles are loading into Meeting Library. We'll tweet a link once the website is fully loaded.

[E_L]

so maybe still to come, but doubt that

[E_L]

Genmab usually sends an email with titles

[Bulder]

Yes, but not before full abstracts are published I think

[Bulder]

I was hoping for Andromeda

[Bulder]

Come to think about it: These titles do not include late breaking. So still a chance.